
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$35.25
−$0.28 · -0.79%
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Previous close
$35.25
−$0.28 · -0.79%
Regular session · ET · Market data may be delayed.
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Day range
Current $35.25
52-week range
Current $35.25
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
69
Undervalued
Sentiment
34
Bearish
Risk
47
Elevated Risk
Momentum
60
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Day range
Current $35.25
52-week range
Current $35.25
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 96.21M USD | 82.25M USD | 68.02M USD | 76.24M USD | 119.16M USD |
| Cost of goods sold | 34.1M USD | 28.58M USD | 26.7M USD | 29.33M USD | 82.11M USD |
| Gross profit | 62.12M USD | 53.67M USD | 41.32M USD | 46.91M USD | 37.05M USD |
| Research and development | 7.57M USD | 7.91M USD | 5.52M USD | 14.8M USD | 11.82M USD |
| Selling, general, and administrative | 55.37M USD | 50.15M USD | 54.17M USD | 44.93M USD | 47.67M USD |
| Operating expenses | 62.94M USD | 60.8M USD | 60.72M USD | 52.83M USD | 67.7M USD |
| Interest expense | 2.71M USD | 719K USD | — | 687K USD | — |
| Depreciation and amortization | 4.69M USD | 8.66M USD | 12.3M USD | 7.58M USD | 12.87M USD |
| Operating income | −1.08M USD | −7.13M USD | −19.4M USD | −5.92M USD | −30.65M USD |
| Net income | −12.13M USD | −20.18M USD | −68M USD | −139.81M USD | −8.91M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR85.4M0.08%109.96B USD0.06%$145.34+0.37%
Vanguard Morningstar Total Stock Market ETFVTI45.71M0.00%2.3T USD0.03%$379.73-0.32%
iShares Russell 2000 ETFIWM39.09M0.05%80.51B USD0.19%$296.01+0.28%
Vanguard Extended Market ETFVXF14.31M0.01%93.7B USD0.05%$242.66+0.14%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM12.88M0.08%16.52B USD0.03%$56.51+0.37%
iShares Russell 2000 Value ETFIWN11.57M0.08%14.61B USD0.24%$224.62+0.40%
Vanguard Russell 2000 ETFVTWO7.5M0.04%17.4B USD0.06%$119.62+0.25%
Schwab U.S. Small-Cap ETFSCHA6.66M0.03%22.93B USD0.03%$34.55+1.01%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
iShares Russell 2000 Value ETFIWN
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHAAI-generated and delayed market data for informational and educational purposes only. Not investment advice.